A recent blog (“Payers and PBMs Profit from Obscure Pharmacy Fees, While Seniors See No Relief in Prescription Costs”) suggests performance-based price concessions are retained by PBMs, restrict the growth of independent pharmacies, and inflate Medicare Part D enrollee’s out-of-pocket costs—unfounded
Pharmacy Direct and Indirect Remuneration (DIR) Value-based Pharmacy Reimbursement Reduces Drug Costs for Medicare Beneficiaries, Lowers Spending. Pharmacy direct and indirect remuneration, or Pharmacy DIR, is a form of value-based contracting in Medicare Part D. Pharmacy DIR increases the quality
Mail-Service Pharmacy Many Americans rely on the mail service pharmacies operated by pharmacy benefit managers (PBMs). Mail-Service Pharmacies provide a convenient, reliable and affordable option for patients to safely access prescription drugs. How does mail-service pharmacy work? Patients may first
In case you missed it, the National Institute for Public Employee Health Care Policy recently released a report, “How Public Sector Health Care Purchasers Are Addressing Rising Drug Costs.” According to the report, “Through pooled purchasing organizations, employers in the
In case you missed it, an expert witness who testified before the U.S. House Committee on Oversight and Accountability during a hearing yesterday on pharmacy benefit companies underscored that misguided policies targeting pharmacy benefits will lead to higher prescription drug
Fact: Employers are under no obligation to hire pharmacy benefit companies, but a vast majority of employers work with pharmacy benefit companies. Recent findings from the PricewaterhouseCoopers (PwC) 2021 “Health and Well-being Touchstone Survey” of 368 companies explains why employers,
This week, community pharmacists will conduct a “Fly-In” in Washington D.C. Undoubtedly, part of the message to Congress will be critical of pharmacy benefit companies, but more than likely what won’t be heard is how PBMs are supporting rural pharmacies
©2024 PCMA. All Rights Reserved.
